miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
about
RAS-MAPK pathway epigenetic activation in cancer: miRNAs in actionExploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer PatientsmiR-34: from bench to bedsideYin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesisHigh-throughput sequencing of microRNA transcriptome and expression assay in the sturgeon, Acipenser schrenckiiOCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell.Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinomaExpression of miR-34c induces G2/M cell cycle arrest in breast cancer cellsMicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasmsWhole genome sequencing of glioblastoma multiforme identifies multiple structural variations involved in EGFR activationDecreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and InvasionMiR-135a and MRP1 play pivotal roles in the selective lethality of phenethyl isothiocyanate to malignant glioma cells.Integration of MicroRNA, mRNA, and Protein Expression Data for the Identification of Cancer-Related MicroRNAs.The impact of post-transcriptional regulation in the p53 network.Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia.Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets.Targeting Cancer Stem Cells with Nanoparticle-Enabled Therapies.An emerging role for microRNAs in NF1 tumorigenesis.Mir-34: a new weapon against cancer?Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.miRNAs as prognostic and therapeutic tools in epithelial ovarian cancer.Glioblastoma: molecular pathways, stem cells and therapeutic targets.MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis.The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.MicroRNA and extracellular vesicles in glioblastoma: small but powerful.MiR-424 functions as a tumor suppressor in glioma cells and is down-regulated by DNA methylation.Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression.Proteomic screening and identification of microRNA-128 targets in glioma cells.Clinical implications of microRNAs in human glioblastomaMiR-34a modulates ionizing radiation-induced senescence in lung cancer cells.MicroRNA-target cross-talks: Key players in glioblastoma multiforme.miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1.Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression.Multiplexed microRNA Expression Profiling by Combined Asymmetric PCR and Label-Free Detection using Silicon Photonic Sensor Arrays
P2860
Q26773479-C779176C-11A7-416B-8BB3-5B49590D96AAQ26796590-BA7443B0-57F5-4E9F-AD43-F441EC83BF03Q26822928-D0A8E0B6-84C9-4FD1-8617-1C8913163D44Q28393225-31EF8952-DEA1-42FE-9E2B-36977DD51424Q28649789-ECAA908E-D00A-4483-86E9-FD396D48EEC5Q33694956-F5DBB368-A805-4BD8-9058-02BC1ABA29B3Q33831315-5E05563C-5471-4160-8CAA-35CDC3CF6520Q33977014-376856F0-A382-4CD9-8833-F4F6A8213E5FQ34017850-D6B72740-D709-4398-A20A-E08833DAD627Q34409620-428471C3-B181-449E-854A-91FDDC63FBB4Q35127713-2D5FBB36-1503-4B7D-9C37-82C202551FD7Q35221471-D22F12CE-B27B-404D-834F-CEF06CE9BBA1Q35680893-CF4B2EBC-D886-4E73-AE0A-A6D7D0CEA05DQ36050048-3387E0C5-C088-4973-AFA7-60E632D1A9DCQ36240247-54871F20-291D-4711-8299-D2C6ECFC023AQ36542788-1D55933E-FA18-4CD4-B4D8-22E4F26BCD21Q37109858-BE29DA4A-7E08-4C62-93F1-C82D2D95B08DQ37335617-2AD5A6B3-2802-434A-9816-347052AF66AAQ37419338-7BA624E6-2030-4827-9B8D-2E3E7C37CC92Q38060281-A7E6815A-AEE4-4BE3-8162-1C24E00C80E5Q38253374-E614405E-A79D-4765-A6FE-B4ABC4094ED4Q38324456-9E71566F-7774-4A6F-95A9-A0023DA78B0EQ38366731-2E00F34E-0962-4068-BC34-AF113D443BAAQ38393328-BEAA43D6-00A9-433B-916C-4E4BB060B755Q38616261-ADCEB592-5DB9-424D-AF4D-26B478D8E4DDQ38683271-2727420A-A484-4C41-A93D-108E68FB7C2EQ38770220-E8604202-50D4-483E-878B-8BE11ACC1EE8Q38784189-35360425-7ED0-4C87-A71B-A4E2C2310FDCQ38844554-E6BCCE92-33E9-4D97-B1F0-94C8008B1E96Q38898532-DB722C3A-B5DD-4401-A550-720343CA7B68Q41872498-54DAFFCF-E7B6-4860-8983-D153BD315B03Q42378381-FBB6E5CE-C41A-4ED2-B7D5-5F638164EC51Q46190130-2B108A38-FC8B-4041-B5B9-BC4F1BCAFF2DQ47660322-E2D2B51B-08AE-4264-B179-812717AF2D4CQ48372076-E023CC77-C152-48DF-8F8B-25ABF1877CCFQ50658268-5A39F875-2DA4-41F2-8BCB-75CE9EBCBBCAQ57146278-AEE7C6EC-888B-4D55-8935-5C199EFB1431
P2860
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
@ast
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
@en
type
label
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
@ast
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
@en
prefLabel
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
@ast
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
@en
P2093
P2860
P356
P1433
P1476
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
@en
P2093
H Phillip Koeffler
N Kawamata
P2860
P2888
P304
P356
10.1038/ONC.2012.132
P407
P577
2012-05-14T00:00:00Z
P5875
P6179
1026559375